Search Results - "Spinler, Sarah A."

Refine Results
  1. 1

    COVID-19 and thrombosis: From bench to bedside by Ali, Mohammad A.M., Spinler, Sarah A.

    Published in Trends in cardiovascular medicine (01-04-2021)
    “…Coronavirus disease of 2019 (COVID-19) is the respiratory viral infection caused by the coronavirus SARS-CoV2 (Severe Acute Respiratory Syndrome Coronavirus…”
    Get full text
    Journal Article
  2. 2

    Dabigatran Etexilate: An Oral Direct Thrombin Inhibitor for Prophylaxis and Treatment of Thromboembolic Diseases by Baetz, Brooke E., Spinler, Sarah A.

    Published in Pharmacotherapy (01-11-2008)
    “…As the only oral anticoagulation option available in the United States, warfarin use remains widespread. However, concerns of safety remain a substantial…”
    Get full text
    Journal Article
  3. 3

    Role of P-glycoprotein in Statin Drug Interactions by Holtzman, Carol W., Wiggins, Barbara S., Spinler, Sarah A.

    Published in Pharmacotherapy (01-11-2006)
    “…Understanding the mechanisms of drug interactions with 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors (statins) has become increasingly important…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Rivaroxaban: An Oral Factor Xa Inhibitor by Thomas, Tyan F., PharmD, Ganetsky, Valerie, PharmD, Spinler, Sarah A., PharmD

    Published in Clinical therapeutics (2013)
    “…Abstract Background Currently available anticoagulants utilized for venous thromboembolism (VTE) treatment and prevention and stroke prevention in patients…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Role of Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Aldosterone Antagonists in the Prevention of Atrial and Ventricular Arrhythmias by Makkar, Kathy M., Sanoski, Cynthia A., Spinler, Sarah A.

    Published in Pharmacotherapy (01-01-2009)
    “…Atrial arrhythmias, ventricular arrhythmias, and sudden cardiac death (SCD) are significant health problems and an economic burden to society. The…”
    Get full text
    Journal Article
  8. 8

    Oral antiplatelet therapy after acute coronary syndrome and percutaneous coronary intervention: Balancing efficacy and bleeding risk by Spinler, Sarah A

    Published in American journal of health-system pharmacy (01-08-2010)
    “…The benefits and risk of bleeding associated with oral antiplatelet agents used for acute coronary syndrome (ACS) or in patients who have undergone…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association by Levine, Glenn N, McEvoy, John W, Fang, James C, Ibeh, Chinwe, McCarthy, Cian P, Misra, Arunima, Shah, Zubair I, Shenoy, Chetan, Spinler, Sarah A, Vallurupalli, Srikanth, Lip, Gregory Y H

    Published in Circulation (New York, N.Y.) (11-10-2022)
    “…Despite the many advances in cardiovascular medicine, decisions concerning the diagnosis, prevention, and treatment of left ventricular (LV) thrombus often…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Emerging Antiplatelet Therapies in Percutaneous Coronary Intervention: A Focus on Prasugrel by Martin, Michelle T., PharmD, BCPS, Spinler, Sarah A., PharmD, FCCP, FCPP, FAHA, FASHP, BCPS, Nutescu, Edith A., PharmD, FCCP

    Published in Clinical therapeutics (01-04-2011)
    “…Abstract Background Prasugrel is the most recent addition to the available thienopyridine antiplatelet agents used to prevent ischemic events in patients with…”
    Get full text
    Journal Article
  14. 14

    Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction by Cheng, Judy W. M., Colucci, Vincent, Kalus, James S., Spinler, Sarah A.

    Published in Annals of Pharmacotherapy (01-11-2023)
    “…Objective: Results from large placebo-controlled randomized trials in patients with heart failure with mid-range ejection fraction (HFmrEF) and HF with…”
    Get full text
    Book Review Journal Article
  15. 15

    Managing acute coronary syndrome: Evidence-based approaches by Spinler, Sarah A

    Published in American journal of health-system pharmacy (01-06-2007)
    “…To describe data and insights from a national quality improvement initiative known as Can Rapid Risk Stratification of Unstable Angina Patients Suppress…”
    Get full text
    Journal Article
  16. 16

    Low-Molecular-Weight Heparins in Renal Impairment and Obesity: Available Evidence and Clinical Practice Recommendations Across Medical and Surgical Settings by Nutescu, Edith A, Spinler, Sarah A, Wittkowsky, Ann, Dager, William E

    Published in The Annals of pharmacotherapy (01-06-2009)
    “…To develop practical recommendations for the use of low-molecular-weight heparins (LMWHs) as prophylaxis and treatment of venous thromboembolism and acute…”
    Get full text
    Journal Article
  17. 17

    Aspirin for primary prevention of cardiovascular disease: a review of recent literature and updated guideline recommendations by Mogul, Amanda, Leppien, Emily E, Laughlin, Elizabeth, Spinler, Sarah A

    Published in Expert opinion on pharmacotherapy (02-01-2021)
    “…Recent clinical trials evaluating the efficacy of aspirin in primary prevention of atherosclerotic cardiovascular disease (ASCVD) have suggested the risk of…”
    Get more information
    Journal Article
  18. 18

    Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin by Spinler, Sarah A, Wittkowsky, Ann K, Nutescu, Edith A, Smythe, Maureen A

    Published in The Annals of pharmacotherapy (01-07-2005)
    “…OBJECTIVE To review the availability, mechanisms, limitations, and clinical application of point-of-care (POC) devices used in monitoring anticoagulation with…”
    Get full text
    Journal Article
  19. 19

    NAPLEX Preparation Program Characteristics and Resources Associated With First-Time Exam Pass Rates by Sobieraj, Diana M, Chen, Aleda M H, Kelsch, Michael P, Lebovitz, Lisa, Spinler, Sarah A, Ray, Mary E

    “…Pharmacy colleges and schools invest substantial faculty effort and financial resources in North America Pharmacist Licensure Exam (NAPLEX) preparation,…”
    Get full text
    Journal Article
  20. 20